Albendazole inhibits NF-κB signaling pathway to overcome tumor stemness and bortezomib resistance in multiple myeloma.
Yi H, Liang L, Wang H, Luo S, Hu L, Wang Y, Shen X, Xiao L, Zhang Y, Peng H, Dai C, Yuan L, Li R, Gong F, Li Z, Ye M, Liu J, Zhou H, Zhang J, Xiao X.
Yi H, et al.
Cancer Lett. 2021 Nov 1;520:307-320. doi: 10.1016/j.canlet.2021.08.009. Epub 2021 Aug 12.
Cancer Lett. 2021.
PMID: 34390764